Aeterna Zentaris Company Profile (NASDAQ:AEZS)

About Aeterna Zentaris

Aeterna Zentaris logoAeterna Zentaris Inc. is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AEZS
  • CUSIP:
Key Metrics:
  • Previous Close: $3.62
  • 50 Day Moving Average: $3.5008
  • 200 Day Moving Average: $3.5018
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.82
  • P/E Growth: 0.0000
  • Market Cap: $36.88M
  • Outstanding Shares: 9,939,000
  • Beta: 1.78
Additional Links:
Companies Related to Aeterna Zentaris:

Analyst Ratings

Consensus Ratings for Aeterna Zentaris (NASDAQ:AEZS) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.67 (194.66% upside)

Analysts' Ratings History for Aeterna Zentaris (NASDAQ:AEZS)
DateFirmActionRatingPrice TargetDetails
8/23/2016Canaccord GenuityReiterated RatingBuy$9.00View Rating Details
8/13/2016Maxim GroupReiterated RatingBuy$11.00View Rating Details
8/11/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 8/26/2014 forward)


Earnings History for Aeterna Zentaris (NASDAQ:AEZS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016Q216($0.82)($0.71)ViewN/AView Earnings Details
3/29/2016Q415($1.30)($1.46)ViewN/AView Earnings Details
11/5/2015Q315($0.06)($0.07)ViewN/AView Earnings Details
8/13/2015Q215($0.08)($0.14)ViewListenView Earnings Details
5/8/2015($0.10)($0.13)ViewN/AView Earnings Details
3/17/2015Q414($0.16)$0.06ViewN/AView Earnings Details
11/4/2014($0.16)($0.20)ViewN/AView Earnings Details
5/8/2014($0.30)($0.08)ViewN/AView Earnings Details
3/20/2014Q413($0.04)($0.22)$12.41 millionViewN/AView Earnings Details
3/21/2013Q412($0.31)($0.29)$7.96 million$9.16 millionViewN/AView Earnings Details
11/13/2012Q312($0.43)($0.35)$8.38 million$7.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aeterna Zentaris (NASDAQ:AEZS)
Current Year EPS Consensus Estimate: $-2.74 EPS
Next Year EPS Consensus Estimate: $-1.99 EPS


Dividend History for Aeterna Zentaris (NASDAQ:AEZS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Aeterna Zentaris (NASDAQ:AEZS)
No insider trades for this company have been tracked by


Latest Headlines for Aeterna Zentaris (NASDAQ:AEZS)
News IconHow the Crowd & Sell-side View AEterna Zentaris Inc. (NASDAQ:AEZS) Shares - Post News (NASDAQ:AEZS) - August 25 at 8:07 AM logoAEterna Zentaris Inc. (NASDAQ:AEZS) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:AEZS) - August 25 at 8:07 AM
News IconCanaccord Genuity Reiterates Buy at Aeterna Zentaris Inc. (NASDAQ: AEZS) - BNB Daily (blog) (NASDAQ:AEZS) - August 24 at 11:37 AM logoCanaccord Positive on AEterna Zentaris Inc. (USA) (AEZS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:AEZS) - August 22 at 8:29 PM
News IconAeterna Zentaris Inc. (AEZ) - Strategic and Financial SWOT Analysis Review (NASDAQ:AEZS) - August 22 at 3:22 PM
News IconHow is the Crowd Rating AEterna Zentaris Inc. (NASDAQ:AEZS) Shares? - Post News (NASDAQ:AEZS) - August 20 at 8:00 AM
News IconAEterna Zentaris Inc. (NASDAQ:AEZS) Stock Update: Wall Street & Retail Analysts Chime in - Post News (NASDAQ:AEZS) - August 18 at 11:44 AM logoWill AEterna Zentaris Inc. (NASDAQ:AEZS) Hit $12 Price Target? - Investor Newswire (NASDAQ:AEZS) - August 17 at 8:51 PM logoMaxim Analyst Shares Two Cents on AEterna Zentaris Inc. (USA) (AEZS) Amid 2Q Update - Smarter Analyst (NASDAQ:AEZS) - August 11 at 3:20 PM logoAeterna Zentaris reports 2Q loss (NASDAQ:AEZS) - August 9 at 9:21 PM
News IconArmune BioScience, Inc. Receives State of Florida Clinical Laboratory License (NASDAQ:AEZS) - August 9 at 12:06 PM logoAeterna Zentaris (AEZS) Brings APIFINY Promotion to The Sunshine State (NASDAQ:AEZS) - August 9 at 12:06 PM logoStock Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) Expands Promotion of APIFINY® into Florida - Smarter Analyst (NASDAQ:AEZS) - August 8 at 3:21 PM
News IconSadif Issues Summary Due Diligence Report on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) - Duncan News (NASDAQ:AEZS) - August 6 at 3:23 PM logoAEterna Zentaris Inc. (AEZS) Updated Price Targets - FTSE News (NASDAQ:AEZS) - August 2 at 3:23 PM logoMaxim Analyst Sees Exceptional Value in AEterna Zentaris Inc. (USA) (AEZS) Following License Agreement Deal for ... - Smarter Analyst (NASDAQ:AEZS) - August 1 at 3:20 PM logo08.01.2016 Aeterna Zentaris and Rafa Laboratories Sign Exclusive License Agreement for Zoptrex™ in Israel (NASDAQ:AEZS) - August 1 at 3:20 PM logoAEterna Zentaris Inc. (AEZS) Updated Price Targets - FTSE ... - FTSE News (NASDAQ:AEZS) - July 29 at 3:20 PM logoCan Shares Of AEterna Zentaris Inc. (NASDAQ:AEZS) Hit $12? - Investor Newswire (NASDAQ:AEZS) - July 27 at 9:04 PM
News IconAre Analysts Bearish AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) After Last Week? - Press Telegraph (NASDAQ:AEZS) - July 23 at 3:19 PM
News IconHow Analysts Feel About AEterna Zentaris Inc. (USA) After Today's ... - Consumer Eagle (NASDAQ:AEZS) - July 22 at 8:21 PM
News IconAEterna Zentaris Inc. (USA)'s Trend Down, Especially After Today's Weak Session - Consumer Eagle (NASDAQ:AEZS) - July 22 at 8:21 PM
News IconCould AEterna Zentaris Inc. (USA) Rise Even More? The Stock Had Another Big Increase Today - Consumer Eagle (NASDAQ:AEZS) - July 22 at 11:30 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for AEterna Zentaris Inc. (NASDAQ:AEZS) - TGP (NASDAQ:AEZS) - July 21 at 3:20 PM logoIs $12 Price Target Attainable For AEterna Zentaris Inc. (NASDAQ:AEZS)? - Investor Newswire (NASDAQ:AEZS) - July 21 at 3:20 PM
News IconAEterna Zentaris Inc. (USA) Can't Be More Risky. Trades Sigfnicicantly Lower - Consumer Eagle (NASDAQ:AEZS) - July 20 at 11:28 AM
News IconAEterna Zentaris Inc. (NASDAQ:AEZS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:AEZS) - July 20 at 11:28 AM
News IconTrading Performance and Target Watch for AEterna Zentaris Inc. (NASDAQ:AEZS) - Press Telegraph (NASDAQ:AEZS) - July 18 at 3:21 PM
News IconAeterna Zentaris Incorporated (NASDAQ:AEZS) Shorted Shares Decreased By 1.49% - Consumer Eagle (NASDAQ:AEZS) - July 17 at 8:05 AM
News IconHow Many AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:AEZS) - July 15 at 1:55 PM logoStrong Sell Calls For AEterna Zentaris Inc. (NASDAQ:AEZS) At 0 - Investor Newswire (NASDAQ:AEZS) - July 13 at 8:53 PM
News IconAeterna Zentaris Incorporated (NASDAQ:AEZS) Sellers Covered 1.49% of Their Shorts - Consumer Eagle (NASDAQ:AEZS) - July 13 at 11:24 AM logoHC Wainwright Analyst Pounds the Table on AEterna Zentaris Inc. (USA) - Smarter Analyst (NASDAQ:AEZS) - July 12 at 3:22 PM
News IconAEterna Zentaris Inc. (NASDAQ:AEZS) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:AEZS) - July 12 at 3:22 PM logoNext Weeks Broker Price Targets For AEterna Zentaris Inc. (AEZS) - Fiscal Standard (NASDAQ:AEZS) - July 10 at 8:07 AM
News IconAeterna Zentaris Incorporated (NASDAQ:AEZS) Short Interest Decreased By 1.49% - Press Telegraph (NASDAQ:AEZS) - July 9 at 11:26 AM logoHot Alert: Aeterna Zentaris Inc. (NASDAQ:AEZS), Kinder Morgan, Inc. (NYSE:KMI), Unifi Inc. (NYSE:UFI), Gorman-Rupp ... - KC Register (NASDAQ:AEZS) - July 8 at 11:23 AM logoNew Broker Ratings For AEterna Zentaris Inc. (AEZS) - FTSE News (NASDAQ:AEZS) - July 7 at 3:20 PM logoAEterna Zentaris Inc. (NASDAQ:AEZS) Expected to Reach Highs Of $12 - Investor Newswire (NASDAQ:AEZS) - July 6 at 9:03 PM logoAnalysts Shine Light On AEterna Zentaris Inc. (USA) (AEZS) And OraSure Technologies, Inc. (OSUR) Following Recent ... - Smarter Analyst (NASDAQ:AEZS) - July 5 at 3:19 PM logoInvestors Are Watching: Aeterna Zentaris Inc. (NASDAQ:AEZS), Pacific Coast Oil Trust (NYSE:ROYT), Aaron's, Inc ... - KC Register (NASDAQ:AEZS) - July 5 at 8:07 AM
News IconRecommendation Trends Analysis: Aeterna Zentaris Inc. (NASDAQ:AEZS) - News Oracle (NASDAQ:AEZS) - July 4 at 3:20 PM logoGaps Up in Stock Trading – PLSE, DFBG, QBAK, TOF, XPLR, ACLS, PTIE (NASDAQ:AEZS) - July 4 at 8:07 AM logoBIND Gallups On Stalking Horse Offer, KBIO Is Back, ALNY Abuzz (NASDAQ:AEZS) - July 4 at 8:07 AM logoAeterna Zentaris (AEZS), Orient EuroPharma Enter License Agreement for Zoptrex in Taiwan and Southeast Asia (NASDAQ:AEZS) - July 2 at 11:02 AM logoMid-Morning Market Update: Markets Open Higher; Micron To Lower Jobs (NASDAQ:AEZS) - July 1 at 11:18 AM logoCompany Update (NASDAQ:AEZS): AEterna Zentaris Inc. (USA) and Orient EuroPharma Sign Exclusive License ... - Smarter Analyst (NASDAQ:AEZS) - July 1 at 11:18 AM logoAeterna Zentaris inks Zoptrex license deal in Asia; shares ahead 10% premarket (NASDAQ:AEZS) - July 1 at 9:52 AM logo07.01.2016 Aeterna Zentaris and Orient EuroPharma Co., Ltd. Sign Exclusive License Agreement for Zoptrex™ in Taiwan and Southeast Asia (NASDAQ:AEZS) - July 1 at 8:51 AM logo8:32 am Aeterna Zentaris signs an exclusive license agreement with Cyntec for Zoptrex, indicated for the treatment of endometrial cancer (NASDAQ:AEZS) - July 1 at 8:32 AM


Aeterna Zentaris (NASDAQ:AEZS) Chart for Friday, August, 26, 2016

Last Updated on 8/26/2016 by Staff